Advertisement

Topics

Perlara PBC Announces Pharma Collaboration

07:14 EDT 19 Oct 2016 | PR Newswire

SAN FRANCISCO, Oct. 19, 2016 /PRNewswire/ -- Perlara PBC (previously Perlstein Lab PBC) today announced the formation of a drug discovery and development collaboration with Novartis to identify new definitive therapeutics for lysosomal storage disorders, starting with lead program Niemann-Pick Type C Disease. In addition to the collaboration, Novartis has made an equity investment in the company. Financial terms are not disclosed.

"Our expertise in whole-animal phenotypic screens, model organism genetics and automation is complemented by Novartis' world-class pathway and chemical biology expertise, clinical experience and global leadership," said Ethan Perlstein, Ph.D., CEO, Perlara PBC. "We are eager to begin this next chapter so that our platform technology and discovery programs can move faster to our goal of helping patients and families impacted by diseases with high unmet need."

Perlara PBC launched in the Spring of 2014 with discovery programs in Niemann-Pick Type C Disease and NGLY1 Deficiency. Earlier this year Perlara PBC received additional seed funding from Y Combinator.

About Perlara PBC

Perlara PBC is a scientific discovery Public Benefit Corporation that works with patients and drug companies to find treatments for diseases previously believed to be too rare to cure. The company is based in San Francisco, California. For more information, please visit us at www.perlara.com, connect with us at @PerlaraPBC on Twitter and at www.facebook.com/PerlaraPBC on Facebook, and learn about our commitment to research transparency and patient engagement on our blog, www.perlara.com/blog.

Logo - http://photos.prnewswire.com/prnh/20161016/429128LOGO

Logo - http://photos.prnewswire.com/prnh/20161016/429127LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/perlara-pbc-announces-pharma-collaboration-300347210.html

SOURCE Perlara PBC

NEXT ARTICLE

More From BioPortfolio on "Perlara PBC Announces Pharma Collaboration"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...